San Francisco, May 1, 2026, 14:41 PDT
Shares of DocuSign Inc. climbed roughly 4.3% Friday, last changing hands at $47.96. Investors circled back to the e-signature firm’s push into AI-based contract management after its fiscal first quarter wrapped up a day ago. The stock’s run-up nudged DocuSign’s market capitalization to just under $10 billion.
Timing is key here. DocuSign’s upcoming report is set to reveal if its Intelligent Agreement Management platform—IAM for short—is finally showing traction beyond just fueling the growth narrative. The IAM software aims to let companies handle contracts end-to-end: storing, reviewing, automating tasks rather than only dispatching documents for electronic signatures.
DocuSign is looking for revenue between $822 million and $826 million for the quarter ended April 30. Guidance for fiscal 2027 lands at $3.484 billion to $3.496 billion in revenue, with annual recurring revenue—its key subscription metric—expected to climb by 8.25% to 8.75%.
March numbers from the company landed on the bullish side. Revenue for the fourth quarter climbed 8% to $836.9 million, with subscription revenue at $819 million. Billings crossed $1 billion for the first time — a milestone for that forward-looking metric.
Chief Executive Allan Thygesen has described IAM as DocuSign’s “agreement system of action,” noting that customers using the platform have produced over $350 million in annual recurring revenue in roughly 18 months. Chief Financial Officer Blake Grayson, speaking to investors, said the March quarter will mark the “last time” the company highlights billings as its primary headline number; focus will move to ARR going forward. Q4 Capital
Cash returns haven’t been ignored. DocuSign’s board tacked on another $2 billion to its share buyback authorization, pushing the total up to $2.6 billion available as of March 17. There’s no requirement for a minimum purchase, and the program doesn’t have a set expiration.
DocuSign maintains size in its main business. The annual report puts customer count above 1.8 million, with global users surpassing a billion. As of Jan. 31, the company also listed over 25,000 IAM customers.
But this pivot comes with clear risks. DocuSign pointed to Adobe Acrobat Sign as its main competitor in global e-signatures and flagged that advances in large language models, generative AI, and general-purpose agents could drive down the costs of contract analysis and make it easier for others to replicate. The company also noted that bigger players might leverage their resources and undercut DocuSign by bundling rival offerings at lower prices.
Wall Street’s still hesitant. According to MarketBeat on Thursday, out of 19 brokerages tracking DocuSign, just three recommend buying. Most – 14 – say hold, and two call it a sell. Since DocuSign’s March results, Robert W. Baird, Wells Fargo, Morgan Stanley, and Royal Bank of Canada all trimmed their targets.
Friday’s action in the stock looks more like a trial run than a decisive reset. DocuSign still has the buyback, profitable subscriptions, and a bigger AI product on the shelf. What investors lack now: proof that IAM can drive growth—without making pricing tougher as Adobe and fresh AI tools get sharper.
